Ballentine Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.09M Sell
17,674
-552
-3% -$63.7K 0.03% 212
2026
Q1
$2.18M Sell
18,226
-118
-0.6% -$15.5K 0.03% 189
2025
Q4
$2.5M Buy
18,344
+1,313
+8% +$189K 0.04% 164
2025
Q3
$2.51M Buy
17,031
+1,170
+7% +$162K 0.03% 166
2025
Q2
$2.05M Sell
15,861
-1,227
-7% -$149K 0.03% 190
2025
Q1
$2.04M Buy
17,088
+8,066
+89% +$1,000K 0.04% 181
2024
Q4
$1.05M Buy
9,022
+504
+6% +$63.7K 0.02% 272
2024
Q3
$1.15M Buy
8,518
+2,086
+32% +$279K 0.02% 257
2024
Q2
$872K Buy
6,432
+53
+0.8% +$7.21K 0.02% 291
2024
Q1
$824K Sell
6,379
-66
-1% -$7.97K 0.02% 286
2023
Q4
$737K Sell
6,445
-919
-12% -$91.7K 0.02% 285
2023
Q3
$670K Sell
7,364
-386
-5% -$39.8K 0.02% 258
2023
Q2
$873K Buy
7,750
+1,271
+20% +$134K 0.02% 217
2023
Q1
$678K Sell
6,479
-317
-5% -$33.1K 0.02% 246
2022
Q4
$751K Buy
6,796
+2,934
+76% +$308K 0.02% 215
2022
Q3
$337K Buy
3,862
+888
+30% +$80.7K 0.01% 310
2022
Q2
$232K Buy
+2,974
New +$246K 0.01% 372
2022
Q1
Sell
-3,920
Closed -$470K 514
2021
Q4
$470K Buy
3,920
+13
+0.3% +$1.61K 0.01% 280
2021
Q3
$483K Buy
3,907
+713
+22% +$91.8K 0.02% 243
2021
Q2
$383K Buy
+3,194
New +$365K 0.01% 278
2017
Q4
Sell
-3,363
Closed -$210K 438
2017
Q3
$210K Buy
+3,363
New +$201K 0.01% 346

Other funds holding XYL

Ballentine Partners's XYL Position: Q2 2026 in Review

Ballentine Partners reduced its Xylem (XYL) stake by 3% in Q2 2026, selling an estimated $63.7K and leaving 17,674 shares worth $2.09M. The position accounts for 0.03% of the portfolio, ranked #212.

Ballentine Partners first reported a position in XYL in Q3 2017 and has held it in 21 quarters since. The position peaked at $2.51M in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Ballentine Partners held 17,674 shares of Xylem worth $2.09M as of Q2 2026.
  • Ballentine Partners sold 552 Xylem shares in Q2 2026, an estimated $63.7K.
  • Xylem made up 0.03% of Ballentine Partners's portfolio in Q2 2026, its #212 holding.
  • Ballentine Partners first reported a position in Xylem in Q3 2017 and has held it in 21 quarters since.
  • Ballentine Partners's Xylem position peaked at $2.51M in Q3 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.